Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-013151

Bellerophon Therapeutics, Inc. · BLPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Robert Nelsen
Director · 10% Owner
Period of report
Feb 12, 2015
Accepted (ET)
Feb 23, 2015 · 9:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 12, 2015D752,994—D0ISee footnote
Common StockF1,F2,F3Feb 12, 2015A752,994—A752,994ISee footnote
Common StockF2,F3Feb 19, 2015P212,666$12.00A965,660ISee footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses